Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives

News

 21st January 2011 Thermo Fisher Scientific

Thermo Fisher Scientific Expands Shanghai Production Capacity

First global company to locally produce cell culture products in China for China

ROCHESTER, N.Y., (January 19, 2011) Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has expanded its state-of-the-art manufacturing facility in Shanghai, China. This latest expansion enables Thermo Fisher to meet growing demand for its Thermo Scientific Nunc Cell Culture products including a range of tissue culture EasY Flasks, dishes, Multidishes and cell culture plates. This is part of a continuing strategy of investment by Thermo Fisher in the regional production and supply of its high-quality cell culture products. The company was the first global company to locally produce cell culture consumable products in China for China.

The Shanghai facility is ISO13485-certified and product quality remains paramount with strict quality controls in place at this facility as well as its other production sites in Rochester, N.Y. and Roskilde, Denmark. Examples include lot release testing of four different cell lines to verify surface performance, use of the same Virgin Polystyrene (PS) resin between all sites and the same Nunclon Delta surface treatment, which has demonstrated superior performance for many years. With these quality measures in place, as well as sterilization performed using ANSI/AAMI/ISO 11137 methods, customers are assured that products supplied from any worldwide facility are of consistent high quality and provide sterility and protection for their valuable cell culture, whatever the application.

For more information on the broad portfolio of cell culture products, please visit www.thermoscientific.com.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.


 

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |